ReviewFrontiers in oncology2018

Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations.

Judith A Seidel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.